Literature DB >> 18817984

The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains.

Y Yasuda1, T Shimoda, K Uno, N Tateishi, S Furuya, K Yagi, K Suzuki, S Fujita.   

Abstract

The effects of MPTP on two mouse strains with different MPTP sensitivities and immunological backgrounds were compared: MPTP-sensitive C57BL/6 mice (B6) with a propensity for Th1 and less MPTP-sensitive BALB/c mice (BALB) with a propensity for Th2. It was found that acute MPTP treatment induced behavioral dysfunction, activated microglia/astrocytes, and increased the levels of IL-10, IL-12(p40) IL-13, IFN-gamma, and MCP-1 in CSF in B6, but not in BALB. This suggests that variances in immunological backgrounds might be a major contributing factor in sensitivity differences to MPTP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817984     DOI: 10.1016/j.jneuroim.2008.08.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  25 in total

Review 1.  Microglial phenotypes in Parkinson's disease and animal models of the disease.

Authors:  Valerie Joers; Malú G Tansey; Giovanna Mulas; Anna R Carta
Journal:  Prog Neurobiol       Date:  2016-04-20       Impact factor: 11.685

Review 2.  Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

Authors:  Katherine E Olson; Aditya N Bade; Charles R Schutt; Jingdong Dong; Scott J Shandler; Michael D Boska; R Lee Mosley; Howard E Gendelman; Yutong Liu
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  Neuromelanin inhibits CXCL10 expression in human astroglial cells.

Authors:  Neda Saffarian Tousi; Daniel J Buck; Luigi Zecca; Randall L Davis
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

4.  Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.

Authors:  Jin-Song Yang; Xiao-Hong Wu; Hao-Gang Yu; Li-Song Teng
Journal:  Inflammopharmacology       Date:  2017-06-02       Impact factor: 4.473

5.  MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Authors:  Mauricio P Cunha; Francis L Pazini; Vicente Lieberknecht; Josiane Budni; Ágatha Oliveira; Júlia M Rosa; Gianni Mancini; Leidiane Mazzardo; André R Colla; Marina C Leite; Adair R S Santos; Daniel F Martins; Andreza F de Bem; Carlos Alberto S Gonçalves; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

6.  Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.

Authors:  Matthew Neal; Jie Luo; Dilshan S Harischandra; Richard Gordon; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Laurent Désaubry; Anumantha Kanthasamy; Arthi Kanthasamy
Journal:  Glia       Date:  2018-09-12       Impact factor: 7.452

7.  Parkinson's disease: is it a toxic syndrome?

Authors:  Seham A Gad Elhak; Abdel Aziz A Ghanem; Hassan Abdelghaffar; Sahar El Dakroury; Mohamed M Salama
Journal:  Neurol Res Int       Date:  2010-09-05

Review 8.  Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.

Authors:  Matthew Neal; Jason R Richardson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-11-04       Impact factor: 5.187

9.  The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease.

Authors:  Josh M Morganti; Kevin R Nash; Bethany A Grimmig; Sonali Ranjit; Brent Small; Paula C Bickford; Carmelina Gemma
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

Review 10.  Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?

Authors:  Anna R Carta; Augusta Pisanu
Journal:  Neurotox Res       Date:  2012-08-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.